The organization includes a network of over 1,000 physicians across the U.S., offering personalized primary care through a concierge model. It serves over 300,000 patients and emphasizes preventive medicine, providing enhanced access to doctors, comprehensive wellness programs, and 24/7 availability. Their approach fosters closer doctor-patient relationships, focusing on proactive healthcare and improved outcomes.

The adoption of the CADScor System is a testament to the organization’s commitment to providing innovative tools for early cardiac assessment. The CADScor System will support physicians in delivering personalized, preventive care to their symptomatic patients suspected of coronary artery disease.

“We are thrilled to partner with a nationally recognized leader in personalized healthcare as we continue to drive our strategy of expanding into targeted verticals such as concierge medicine,” commented Aamir Mahmood, Acarix President and CEO. “This order represents a significant step forward in our mission to make rapid and accurate cardiac diagnostics at point of care accessible to more patients and physicians.”

This achievement builds on the solid momentum reported in Acarix’s Q2 2024 earnings, where the company highlighted record patch sales and gross profit alongside a strategic focus on expanding into new healthcare segments. This partnership emphasizes Acarix’s commitment to growth and its ongoing efforts to transform early cardiac diagnostics.